1. Home
  2. NATL vs IDYA Comparison

NATL vs IDYA Comparison

Compare NATL & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NATL
  • IDYA
  • Stock Information
  • Founded
  • NATL 2023
  • IDYA 2015
  • Country
  • NATL United States
  • IDYA United States
  • Employees
  • NATL N/A
  • IDYA N/A
  • Industry
  • NATL
  • IDYA Biotechnology: Pharmaceutical Preparations
  • Sector
  • NATL
  • IDYA Health Care
  • Exchange
  • NATL Nasdaq
  • IDYA Nasdaq
  • Market Cap
  • NATL 1.8B
  • IDYA 1.9B
  • IPO Year
  • NATL N/A
  • IDYA 2019
  • Fundamental
  • Price
  • NATL $29.51
  • IDYA $22.10
  • Analyst Decision
  • NATL Buy
  • IDYA Strong Buy
  • Analyst Count
  • NATL 4
  • IDYA 13
  • Target Price
  • NATL $38.75
  • IDYA $53.42
  • AVG Volume (30 Days)
  • NATL 429.4K
  • IDYA 1.0M
  • Earning Date
  • NATL 08-12-2025
  • IDYA 08-05-2025
  • Dividend Yield
  • NATL N/A
  • IDYA N/A
  • EPS Growth
  • NATL N/A
  • IDYA N/A
  • EPS
  • NATL 1.55
  • IDYA N/A
  • Revenue
  • NATL $4,247,000,000.00
  • IDYA $7,000,000.00
  • Revenue This Year
  • NATL $1.81
  • IDYA $101.20
  • Revenue Next Year
  • NATL $4.37
  • IDYA $286.70
  • P/E Ratio
  • NATL $19.03
  • IDYA N/A
  • Revenue Growth
  • NATL N/A
  • IDYA N/A
  • 52 Week Low
  • NATL $22.30
  • IDYA $13.45
  • 52 Week High
  • NATL $35.50
  • IDYA $44.42
  • Technical
  • Relative Strength Index (RSI)
  • NATL 59.32
  • IDYA 58.41
  • Support Level
  • NATL $28.19
  • IDYA $20.50
  • Resistance Level
  • NATL $30.78
  • IDYA $22.86
  • Average True Range (ATR)
  • NATL 0.91
  • IDYA 0.95
  • MACD
  • NATL 0.07
  • IDYA -0.13
  • Stochastic Oscillator
  • NATL 68.09
  • IDYA 67.71

About NATL NCR Atleos Corporation

NCR Atleos Corp is financial technology company providing self-directed banking solutions to a customer base including financial institutions, merchants, manufacturers, retailers and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware and its proprietary Allpoint network. Atleos manage its operations in the following segments which includes Self-Service Banking, Network, and Telecommunications abd Technology.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: